Ibrutinib superior to traditional chemotherapy in untreated chronic leukemia patients

A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated that ibrutinib, a kinase inhibitor, is significantly more effective than traditional chemotherapy with chlorambucil. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail